Quality of Life in Chinese Postmenopausal HR(+) Early Breast Cancer (EBC) Patients During Adjuvant Aromatase Inhibitors(AIs) Treatment

CompletedOBSERVATIONAL
Enrollment

494

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Breast Cancer
Trial Locations (15)

Unknown

Research Site, Beijing

Research Site, Guangzhou

Research Site, Shenzhen

Research Site, Guiyang

Research Site, Harbin

Research Site, Changsha

Research Site, Nanjing

Research Site, Changchun

Research Site, Shanghai

Research Site, Xi’an

Research Site, Tianjin

Research Site, Kunming

Research Site, Hangzhou

Research Site, Ningbo

Research Site, Wenzhou

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY